Author

Poynard T

12 novembre 2013
Le nouveau paradigme de la thérapie contre l'hépatite C: intégration des thérapies orales dans les meilleures pratiques
Summary Collaborators New Paradigm of HCV Therapy Meeting Participants: Nezam H Afdhal, Rachel Baden, Cynthia Beam, Julie Krop, Clifford Brass, David Brumley, Laurent Castera, Daniel Church, Alfred DeMaria Jr, Kevin Cranston, Lynda Dee, Arnold Doyle, Julia Engstrom-Melnyk, Michael Fried, Camilla Graham, Michael Wong, William Guyer, John G McHutchison, Joe Steele, William Symonds, Ira M Jacobson, Alain Litwin, Anthony Martinez, Andrew Talal, Henry Masur, Douglas Mayers, Ronald C Renaud Jr, Shruti H Mehta, Andrew Muir, Christopher J Myatt, Stanley J Naides, Rick Pesano, William O’Brien, Christos J Petropoulos, Gastón R Picchio, Thierry […]

En savoir plus
6 mai 2013
Fardeau et coût de la maladie du virus de l'hépatite C chronique (VHC) aux États-Unis
Summary Hepatitis C virus (HCV) infection is a leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation. A better understanding of HCV disease progression and the associated cost can help the medical community manage HCV and develop treatment strategies in light of the emergence of several potent anti-HCV therapies. A system dynamic model with 36 […]

En savoir plus
8 juin 2011
Une revue systématique de l'épidémiologie du virus de l'hépatite C en Europe, au Canada et en Israël
Summary Background and Aim Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Methodology Data references […]

En savoir plus